These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 10063271

  • 1. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL, Hong YR, Sy WD, Chai CY, Lin HJ, Howng SL.
    J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
    [Abstract] [Full Text] [Related]

  • 2. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 3. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 4. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B, Petmitr S, Ponglikitmongkol M, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Anticancer Res; 2001 Sep; 21(4A):2739-43. PubMed ID: 11724349
    [Abstract] [Full Text] [Related]

  • 5. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 6. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
    Patt S, Gries H, Giraldo M, Cervos-Navarro J, Martin H, Jänisch W, Brockmöller J.
    Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
    [Abstract] [Full Text] [Related]

  • 7. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 8. Role of gemistocytes in astrocytoma progression.
    Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1997 Feb 01; 76(2):277-84. PubMed ID: 9042164
    [Abstract] [Full Text] [Related]

  • 9. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 01; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 10. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S.
    Brain Tumor Pathol; 2010 Oct 01; 27(2):95-101. PubMed ID: 21046311
    [Abstract] [Full Text] [Related]

  • 11. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 01; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 12. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan 01; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 13. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 May 15; 52(10):2987-90. PubMed ID: 1349850
    [Abstract] [Full Text] [Related]

  • 14. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing.
    Hunter SB, Bandea C, Swan D, Abbott K, Varma VA.
    Mod Pathol; 1993 Jul 15; 6(4):442-5. PubMed ID: 8415589
    [Abstract] [Full Text] [Related]

  • 15. Timing of p53 mutations during astrocytoma tumorigenesis.
    del Arco A, García J, Arribas C, Barrio R, Blázquez MG, Izquierdo JM, Izquierdo M.
    Hum Mol Genet; 1993 Oct 15; 2(10):1687-90. PubMed ID: 8268922
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical pattern of P53 protein in human astrocytic tumors.
    Howng SL, Hwang SL, Chai CY, Lin HJ.
    Kaohsiung J Med Sci; 1996 May 15; 12(5):279-84. PubMed ID: 8676433
    [Abstract] [Full Text] [Related]

  • 17. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M.
    J Neuropathol Exp Neurol; 2007 Oct 15; 66(10):944-54. PubMed ID: 17917588
    [Abstract] [Full Text] [Related]

  • 18. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T, Fujii T, Yabe M, Oka K, Hoshi T, Sato K.
    Histopathology; 1998 Nov 15; 33(5):446-52. PubMed ID: 9839169
    [Abstract] [Full Text] [Related]

  • 19. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD, Shastry AH, Arivazhagan A, Santosh V.
    Pathol Res Pract; 2016 Jan 15; 212(1):17-23. PubMed ID: 26616112
    [Abstract] [Full Text] [Related]

  • 20. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H.
    Acta Neuropathol; 1998 Jun 15; 95(6):559-64. PubMed ID: 9650746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.